“Drug corporations clearly are taking advantage… and abusing their monopoly privileges—and everyone in the U.S. is paying for it,” says Public Citizen’s Peter Maybarduk.
Source: ‘Eye-Popping Rip-Off’: Americans Pay Nearly Double Rest of World Combined for Top Meds
